Authors of a pharmacist-directed transitions of care study discuss what drives pneumococcal vaccine hesitancy and how pharmacists can build systematic vaccine screening into inpatient workflows.
|Articles|April 27, 2022
Daily OTC Pearl: Levocetirizine Dihydrochloride Allergy Relief
Author(s)Saro Arakelians, PharmD
OTC levocetirizine dihydrochloride antihistamine is indicated for allergy symptoms, such as runny nose and sneezing.
Advertisement
OTC/Lifestyle Pearl of the Day: Allergy Relief Medication
Indication: OTC levocetirizine dihydrochloride antihistamine is indicated for allergy symptoms, such as runny nose and sneezing.
Insight:
- Ingredients: Colloidal silicon dioxide, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, titanium dioxide.
- Active ingredient: Levocetirizine
- Do not use if you have kidney disease, if you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing cetirizine.
- Stop use and consult a physician if you have trouble urinating or emptying your bladder, or an allergic reaction to the product occurs.
- When using this product drowsiness may occur. Avoid alcoholic drinks, sedatives, and tranquilizers, which may increase drowsiness. Be careful when driving a motor vehicle or operating machinery.
- For 24-hour relief for allergy symptoms
Source:
Advertisement
Related to this article
HYPERION trial data now support sotatercept within a patient's first year of pulmonary arterial hypertension (PAH) diagnosis, cutting clinical worsening risk by 76% compared with placebo.
A stewardship program combining EHR alerts and pharmacist-led education offers a replicable model for reducing bleeding risk.
Tim Cernohous of Cencora explains why patient trust no longer guarantees satisfaction—and how automation and better communication can close the gap with mail order.
Eight Humira biosimilars have been launched, but payer formularies and interchangeability rules decide what dispenses.
At NEIAP 2026, Kelsey Norman, PharmD, walked through how VESALIUS-CV, Lp(a)HORIZON, and CKM guidelines change pharmacist-led lipid care.
Pharmacists can educate patients about staying up to date on immunizations and discuss fall prevention strategies.
Findings presented at the European Respiratory Society Congress 2026 suggest semaglutide may offer respiratory benefits beyond its approved diabetes and obesity indications.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Bridging the Gap: Pharmacist Experiences Obtaining DEA Licenses
2
Eight Names, One Drug: Why Adalimumab Biosimilars Are Creating Real Confusion at the Counter
3
Expert Q&A: Pharmacists Address Pneumococcal Vaccine Hesitancy and Screening Complexity in Transitions of Care
4
Etentamig Reduces Risk of Progression or Death by 60% in Relapsed/Refractory Multiple Myeloma
5